Published in J Clin Pathol on July 01, 2001
Intra-operative rapid diagnostic method based on CK19 mRNA expression for the detection of lymph node metastases in breast cancer. Int J Cancer (2008) 1.39
Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology. J Clin Pathol (2004) 1.19
Complete sectioning of axillary sentinel nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients. J Clin Pathol (2002) 1.11
Multicenter study evaluating the clinical performance of the OSNA assay for the molecular detection of lymph node metastases in gastric cancer patients. Gastric Cancer (2013) 0.99
The value of cytokeratin immunohistochemistry in the evaluation of axillary sentinel lymph nodes in patients with lobular breast carcinoma. J Clin Pathol (2006) 0.98
Determinants of diagnostic performance of [F-18]fluorodeoxyglucose positron emission tomography for axillary staging in breast cancer. Ann Surg (2002) 0.97
Multiparameter flow cytometry as a tool for the detection of micrometastatic tumour cells in the sentinel lymph node procedure of patients with breast cancer. J Clin Pathol (2002) 0.95
A model for determining the optimum histology of sentinel lymph nodes in breast cancer. J Clin Pathol (2004) 0.91
Sentinel lymph node investigation in melanoma: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol (2004) 0.87
Supervised automated microscopy increases sensitivity and efficiency of detection of sentinel node micrometastases in patients with breast cancer. J Clin Pathol (2004) 0.83
Accurate and rapid novel genetic diagnosis for detection of sentinel lymph node metastasis in breast cancer patients. Br J Cancer (2012) 0.82
The value of dual-time-point 18F-FDG PET/CT for identifying axillary lymph node metastasis in breast cancer patients. Br J Radiol (2010) 0.78
Histologic evaluation of sentinel and non-sentinel axillary lymph nodes in breast cancer by multilevel sectioning and predictors of non-sentinel metastasis. Gland Surg (2014) 0.75
Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg (1994) 8.85
The sentinel node in breast cancer--a multicenter validation study. N Engl J Med (1998) 8.48
Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet (1997) 6.99
Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet (1999) 3.50
Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst (1999) 2.90
Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg (1997) 2.49
Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study. Cancer (2000) 2.29
Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg (1998) 2.02
Reliability of intraoperative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer. Histopathology (1999) 1.84
Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. Am J Surg Pathol (1999) 1.82
Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: A preliminary study. Cancer (1999) 1.77
The implementation of the sentinel node biopsy as a routine procedure for patients with breast cancer. Surgery (2000) 1.61
State-of-the-art approaches to sentinel node biopsy for breast cancer: study design, patient selection, technique, and quality control at Memorial Sloan-Kettering Cancer Center. Surg Oncol (1999) 1.52
Serial sectioning of sentinel nodes in patients with breast cancer: a pilot study. Ann Surg Oncol (1998) 1.52
Histopathological workup of sentinel lymph nodes: how much is enough? J Clin Pathol (1999) 1.25
Metastases in axillary sentinel lymph nodes in breast cancer as detected by intensive histopathological work up. J Clin Pathol (1999) 1.18
Lymphatic mapping and sentinel lymph node biopsy in patients with breast cancer. Annu Rev Med (2000) 0.97
Occult axillary lymph node metastases in invasive breast carcinoma: characteristics of the primary tumor and significance of the metastases. Pathol Annu (1982) 0.97
See one, do twenty-five, teach one: the implementation of sentinel node dissection in breast cancer. Ann Surg Oncol (1999) 0.96
Sentinel node biopsy in the staging of breast cancer. Am J Surg (1998) 0.95
Mapping metastases in sentinel lymph nodes of breast cancer. Am J Clin Pathol (2000) 0.87
Immunohistochemical detection of lymph-node metastases. Lancet (2000) 0.85
Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol (2004) 6.47
Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J Natl Cancer Inst (2001) 4.27
Efficacy of 'radioguided occult lesion localisation' (ROLL) versus 'wire-guided localisation' (WGL) in breast conserving surgery for non-palpable breast cancer: a randomised controlled multicentre trial. Breast Cancer Res Treat (2012) 3.99
Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. J Pathol (2001) 3.94
Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial. Lancet (1999) 3.25
Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol (2000) 3.20
Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med (1989) 2.94
Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1). J Pathol (2005) 2.70
Lack of specific renal haemodynamic effects of different doses of dopamine after infrarenal aortic surgery. Br J Anaesth (1996) 2.67
Intradermal blue dye to identify sentinel lymph-node in breast cancer. Lancet (1997) 2.60
Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent. Int J Cancer (1993) 2.60
Doxorubicin gradients in human breast cancer. Clin Cancer Res (1999) 2.36
Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns. J Pathol (2001) 2.33
Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer. J Clin Pathol (2005) 2.10
Radioactive seed localization for non-palpable breast cancer. Br J Surg (2013) 2.07
Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations. Gynecol Oncol (2000) 2.04
Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg (1998) 2.02
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. Biochim Biophys Acta (2002) 1.98
Relationships between vascularization and proliferation in invasive breast cancer. J Pathol (1999) 1.90
Reliability of intraoperative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer. Histopathology (1999) 1.84
Activated cytotoxic T cells as prognostic marker in Hodgkin's disease. Blood (1997) 1.82
[The sentinel node procedure: standard intervention for surgical treatment of breast cancer]. Ned Tijdschr Geneeskd (1998) 1.76
Heterogeneity and reproducibility of microvessel counts in breast cancer. Lab Invest (1995) 1.75
Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops. J Pathol (1998) 1.62
The implementation of the sentinel node biopsy as a routine procedure for patients with breast cancer. Surgery (2000) 1.61
Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin. J Clin Oncol (2000) 1.60
A comparison of three methods for nonpalpable breast cancer excision. Eur J Surg Oncol (2010) 1.59
Expression of differentiation and proliferation related proteins in epithelium of prophylactically removed ovaries from women with a hereditary female adnexal cancer predisposition. Histopathology (2003) 1.59
Interlaboratory reproducibility of semiautomated cell cycle analysis of flow cytometry DNA-histograms obtained from fresh material of 1,295 breast cancer cases. Hum Pathol (1996) 1.58
Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis. J Pathol (1998) 1.58
The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2alpha. Oncogene (2007) 1.57
Comparative genomic hybridisation. Mol Pathol (1999) 1.56
New horizons in colorectal cancer surgery. Surg Endosc (2008) 1.55
Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation. J Clin Pathol (1998) 1.54
Prospective randomised trial of early dietary protein restriction in chronic renal failure. Lancet (1984) 1.53
Selection of patients for resection of colorectal metastases to the liver using diagnostic laparoscopy and laparoscopic ultrasonography. Ann Surg (1999) 1.49
Clinical and genetic evaluation of thirty ovarian cancer families. Am J Obstet Gynecol (1998) 1.49
Extended neoadjuvant chemotherapy in locally advanced breast cancer combined with GM-CSF: effect on tumour-draining lymph node dendritic cells. Eur J Cancer (2003) 1.48
Hypoxia-inducible factor-1alpha is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer. Histopathology (2005) 1.47
Localization of regional lymph nodes in melanomas of the head and neck. Arch Otolaryngol Head Neck Surg (1998) 1.43
Successful surgical treatment of parathyroid carcinoma in two haemodialysis patients. Nephrol Dial Transplant (1990) 1.43
In-transit lymph node metastases in breast cancer: a possible source of local recurrence after Sentinel Node procedure. J Clin Pathol (2008) 1.42
Impactitis: new cures for an old disease. J Clin Pathol (2001) 1.42
[The historical perspective of the sentinel lymph node concept]. Ned Tijdschr Geneeskd (2008) 1.42
Histopathology of fibroadenoma of the breast. Am J Clin Pathol (2001) 1.41
DNA profiling of primary serous ovarian and fallopian tube carcinomas with array comparative genomic hybridization and multiplex ligation-dependent probe amplification. J Pathol (2007) 1.40
Kupffer cell depletion by CI2MDP-liposomes alters hepatic cytokine expression and delays liver regeneration after partial hepatectomy. Liver (2000) 1.39
Unimpaired immune functions after laparoscopic cholecystectomy. Surgery (1994) 1.39
[Breast self-examination also valuable in women participating in a screening programme]. Ned Tijdschr Geneeskd (2008) 1.39
Quality control methods for data entry in pathology using a computerized data management system based on an extended data dictionary. Hum Pathol (1992) 1.38
Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer. Arch Surg (2001) 1.34
Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast. Mol Pathol (2000) 1.34
Acute and cumulative effects of carboplatin on renal function. Br J Cancer (1989) 1.33
Primary extranodal non-Hodgkin lymphoma of the oral cavity. An analysis of 34 cases. Eur J Cancer B Oral Oncol (1994) 1.31
Lymphoscintigraphy and SPECT/CT in multicentric and multifocal breast cancer: does each tumour have a separate drainage pattern? Results of a Dutch multicentre study (MULTISENT). Eur J Nucl Med Mol Imaging (2012) 1.29
Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach. J Clin Pathol (1999) 1.28
Gamma probe-guided sentinel node biopsy to select patients with melanoma for lymphadenectomy. Br J Surg (1994) 1.27
Functional lymphatic anatomy for sentinel node biopsy in breast cancer: echoes from the past and the periareolar blue method. Ann Surg (2000) 1.27
Ultrasound-guided lumpectomy of nonpalpable breast cancer versus wire-guided resection: a randomized clinical trial. Ann Surg Oncol (2002) 1.27
Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution. J Pathol (2001) 1.26
Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med (1997) 1.25
Histopathological workup of sentinel lymph nodes: how much is enough? J Clin Pathol (1999) 1.25
The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma. Cancer (2001) 1.25
Lack of lymphangiogenesis during breast carcinogenesis. J Clin Pathol (2004) 1.25
Distinction between hereditary and sporadic breast cancer on the basis of clinicopathological data. J Clin Pathol (2006) 1.24
5-Fluorouracil incorporation into RNA and DNA in relation to thymidylate synthase inhibition of human colorectal cancers. Ann Oncol (2004) 1.23
Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer. Br J Cancer (1998) 1.23
Molecular imaging of breast cancer. Breast (2009) 1.22
Prognostic role of thymidylate synthase, thymidine phosphorylase/platelet-derived endothelial cell growth factor, and proliferation markers in colorectal cancer. Clin Cancer Res (2000) 1.21
Ultrasound-guided laser-induced thermal therapy for small palpable invasive breast carcinomas: a feasibility study. Ann Surg Oncol (2009) 1.20
Systemic and peritoneal inflammatory response after laparoscopic or conventional colon resection in cancer patients: a prospective, randomized trial. Dis Colon Rectum (2003) 1.18
Interplay between VHL/HIF1alpha and Wnt/beta-catenin pathways during colorectal tumorigenesis. Oncogene (2006) 1.17
Thymidylate synthase inhibition after administration of fluorouracil with or without leucovorin in colon cancer patients: implications for treatment with fluorouracil. J Clin Oncol (1994) 1.17
Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases. Am J Pathol (2000) 1.16
Lymph node negative colorectal cancers with isolated tumor deposits should be classified and treated as stage III. Ann Surg Oncol (2010) 1.15
Loss of lamin A/C expression in stage II and III colon cancer is associated with disease recurrence. Eur J Cancer (2011) 1.14
Current technologies for HER2 testing in breast cancer. Crit Rev Oncol Hematol (2011) 1.14
Prognostic relevance of P-glycoprotein expression in breast cancer. Ann Oncol (1995) 1.13
Role of Kupffer cells in arresting circulating tumor cells and controlling metastatic growth in the liver. Hepatology (1996) 1.12
Methylation is less abundant in BRCA1-associated compared with sporadic breast cancer. Ann Oncol (2008) 1.12
Diagnosis of breast lesions: fine-needle aspiration cytology or core needle biopsy? A review. J Clin Pathol (2011) 1.12
Humoral immune response to polymorphic epithelial mucin (MUC-1) in patients with benign and malignant breast tumours. Eur J Cancer (1996) 1.11
Hot spot microvessel density and the mitotic activity index are strong additional prognostic indicators in invasive breast cancer. Histopathology (2000) 1.10
Histopathology of retrieved allografts of the femoral head. J Bone Joint Surg Br (1999) 1.10
Effects of chemotherapy on pathologic and biologic characteristics of locally advanced breast cancer. Am J Clin Pathol (1997) 1.10
The devastating outcome of massive subcutaneous injection of highly viscous fluids in male-to-female transsexuals. Plast Reconstr Surg (2001) 1.10
Some effects of combination chemotherapy with cis-platinum on renal function in patients with nonseminomatous testicular carcinoma. Cancer (1983) 1.09
Increased soluble interleukin-1 type II receptor concentrations in postoperative patients and in patients with sepsis syndrome. Blood (1996) 1.09
The Multicenter Morphometric Mammary Carcinoma Project (MMMCP). A nationwide prospective study on reproducibility and prognostic power of routine quantitative assessments in The Netherlands. Pathol Res Pract (1989) 1.09